Patients with prognostically favorable genetic subtypes (CBFB::MYH11, RUNX1::RUNX1T1, CEBPAm and NPM1m) were treated predominantly on the SR arm of the AML-BFM 2012 Registry protocol. The gene discussed is CBFB; the disease is acute myeloid leukemia.